SG11201503854UA - Method for producing parvovirus having high infectivity titer - Google Patents
Method for producing parvovirus having high infectivity titerInfo
- Publication number
- SG11201503854UA SG11201503854UA SG11201503854UA SG11201503854UA SG11201503854UA SG 11201503854U A SG11201503854U A SG 11201503854UA SG 11201503854U A SG11201503854U A SG 11201503854UA SG 11201503854U A SG11201503854U A SG 11201503854UA SG 11201503854U A SG11201503854U A SG 11201503854UA
- Authority
- SG
- Singapore
- Prior art keywords
- infectivity titer
- high infectivity
- producing parvovirus
- parvovirus
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14351—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012256801 | 2012-11-22 | ||
PCT/JP2013/073906 WO2014080676A1 (en) | 2012-11-22 | 2013-09-05 | Method for producing parvovirus having high infectivity titer |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201503854UA true SG11201503854UA (en) | 2015-06-29 |
Family
ID=50775867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201503854UA SG11201503854UA (en) | 2012-11-22 | 2013-09-05 | Method for producing parvovirus having high infectivity titer |
Country Status (7)
Country | Link |
---|---|
US (1) | US9809800B2 (en) |
EP (1) | EP2924114B1 (en) |
JP (1) | JP5980947B2 (en) |
KR (1) | KR101624089B1 (en) |
CN (1) | CN104812893B (en) |
SG (1) | SG11201503854UA (en) |
WO (1) | WO2014080676A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101645230B1 (en) * | 2015-05-04 | 2016-08-03 | 가톨릭대학교 산학협력단 | Process for viral proliferation and application thereof |
EP3372677B8 (en) * | 2015-11-06 | 2019-09-25 | Asahi Kasei Medical Co., Ltd. | Method for producing parvovirus having high infectivity titer and high purity |
EP3321357A1 (en) * | 2016-11-09 | 2018-05-16 | Deutsches Krebsforschungszentrum | Scalable process for oncolytic rat parvovirus h-1 production and purification based on isoelectric point-based elimination of empty particles |
CN106591242B (en) * | 2016-11-18 | 2019-08-30 | 北京世纪元亨动物防疫技术有限公司 | One plant of canine parvovirus poison strain CPV-YH and its application |
WO2021172573A1 (en) | 2020-02-28 | 2021-09-02 | 旭化成メディカル株式会社 | Method for evaluating viral clearance performance |
CN112359140A (en) * | 2020-11-06 | 2021-02-12 | 苏州药明检测检验有限责任公司 | Method for determining titer of mouse parvovirus by using plaque staining |
EP4317460A1 (en) | 2021-03-26 | 2024-02-07 | Asahi Kasei Medical Co., Ltd. | Viral clearance test method |
CN114107170B (en) * | 2021-11-12 | 2023-08-29 | 广东省华晟生物技术有限公司 | Cat kidney suspension cell line and construction method and application thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5822008B2 (en) | 1975-08-07 | 1983-05-06 | デユフアル・インテルナチオナル・レセ−ルフ・ベ−・ヴエ− | Feline herpesvirus vaccine |
JPS5822008A (en) | 1981-07-31 | 1983-02-09 | 中村 憲司 | Cosmetic puff and method |
JPS6124370A (en) | 1984-07-12 | 1986-02-03 | Olympus Optical Co Ltd | Area gradation recording method |
US4870023A (en) | 1987-03-16 | 1989-09-26 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
WO1988007082A1 (en) * | 1987-03-16 | 1988-09-22 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
US4904468A (en) | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
JP3982843B2 (en) | 1994-05-24 | 2007-09-26 | 旭化成メディカル株式会社 | Method for sequential culture of animal cells using porous carrier |
US5814510A (en) | 1994-11-08 | 1998-09-29 | Cornell Research Foundation, Inc. | Attenuated canine parvovirus vaccine |
GB9716611D0 (en) | 1997-08-07 | 1997-10-08 | Cantab Pharmaceuticals Res Ltd | Virus preparations and methods |
BR9804283B1 (en) | 1998-03-18 | 2010-11-30 | process for producing low density flaviviruses from cultured cells and process for producing low density recombinant flaviviruses from cultured cells. | |
US7179456B2 (en) * | 2003-04-30 | 2007-02-20 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Use of parvovirus for brain tumor therapy |
EP2017333B1 (en) | 2006-04-28 | 2011-10-12 | Kyoritsu Seiyaku Corporation | Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell |
EP1985305A1 (en) | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
US8202726B2 (en) * | 2008-09-24 | 2012-06-19 | Medimmune, Llc | Methods for cultivating cells, propagating and purifying viruses |
BR112012026095A2 (en) | 2010-04-14 | 2015-09-15 | Emd Millipore Corp | methods of producing high purity virus stocks and high titers and methods of using them. |
CN107254451B (en) | 2010-07-16 | 2021-12-10 | 英特维特国际股份有限公司 | Live attenuated parvovirus |
CN101947318B (en) * | 2010-09-09 | 2012-09-05 | 扬州优邦生物制药有限公司 | Method for preparing porcine parvovirus inactivated vaccines |
-
2013
- 2013-09-05 SG SG11201503854UA patent/SG11201503854UA/en unknown
- 2013-09-05 US US14/646,115 patent/US9809800B2/en active Active
- 2013-09-05 EP EP13856565.0A patent/EP2924114B1/en active Active
- 2013-09-05 WO PCT/JP2013/073906 patent/WO2014080676A1/en active Application Filing
- 2013-09-05 CN CN201380061077.3A patent/CN104812893B/en active Active
- 2013-09-05 KR KR1020157005524A patent/KR101624089B1/en active IP Right Grant
- 2013-09-05 JP JP2014548483A patent/JP5980947B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9809800B2 (en) | 2017-11-07 |
WO2014080676A1 (en) | 2014-05-30 |
EP2924114A1 (en) | 2015-09-30 |
CN104812893B (en) | 2018-08-03 |
CN104812893A (en) | 2015-07-29 |
KR20150038568A (en) | 2015-04-08 |
EP2924114B1 (en) | 2016-12-07 |
US20150299668A1 (en) | 2015-10-22 |
EP2924114A4 (en) | 2015-10-28 |
KR101624089B1 (en) | 2016-05-24 |
JP5980947B2 (en) | 2016-08-31 |
JPWO2014080676A1 (en) | 2017-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201404014PA (en) | Methods for increasing the infectivity of viruses | |
SG11201404361UA (en) | Methods for increasing the infectivity of viruses | |
EP2940004A4 (en) | Method for producing oxime | |
PL3903906T3 (en) | Method for cleaning air | |
SG11201503854UA (en) | Method for producing parvovirus having high infectivity titer | |
PL2825212T3 (en) | Improved sterilization method | |
EP2889300A4 (en) | Method for producing aromatic compound | |
SG11201400236YA (en) | Viral clearance methods | |
ZA201404759B (en) | Method for preparing high-silica lev-type zeolites | |
SG11201601994VA (en) | Method for preparing zeolite ssz-35 | |
EP3020808A4 (en) | Method for manufacturing non-enveloped virus | |
EP2837619A4 (en) | Method for producing beta -alkoxypropionamide | |
PL2890639T3 (en) | Novel method for preparing precipitated silicas | |
BR112014023401A2 (en) | method for producing punch-roll bung | |
EP2907863A4 (en) | Method for producing phosphor | |
EP2837598A4 (en) | Method for producing alumina | |
EP2824130A4 (en) | Method for producing polydialkylsilane | |
HK1201691A1 (en) | Sterilization method | |
EP2847331A4 (en) | Method for producing terpenes | |
SI3202769T1 (en) | Purification method for phosphaplatin compounds | |
EP2876084A4 (en) | Method for producing maz-type zeolite | |
EP2935104A4 (en) | Uzm-43 an euo-nes-non zeolite | |
EP2871199A4 (en) | Method for producing aromatic compound | |
SG11201602017YA (en) | Method for producing enveloped viruses | |
SG11201601934YA (en) | Method for preparing zeolite ssz-35 |